We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




External Cephalic Version Lacks Adverse Outcomes

By HospiMedica International staff writers
Posted on 10 Aug 2018
Efforts to reposition a fetus in the breech position via external cephalic version (ECV) significantly improve the likelihood of a vaginal delivery, according to a new study.

Researchers at Northwestern University (NU; Chicago, IL, USA) conducted a retrospective cohort study of 4,117 women with singleton gestations in non-vertex presentation that delivered during a 10-year period (2006 to 2016). More...
Women undergoing an ECV attempt at 37 weeks of gestation or greater were compared with those with non-vertex fetuses who did not undergo an ECV attempt. The primary outcome was a composite of perinatal morbidity and mortality. Secondary outcomes included neonatal intensive care unit (NICU) admission and neonatal anemia.

ECV was attempted in only about a third (30.7%) of the women, with 40.3% of the attempts resulting in successful repositioning of the fetus. For both the primary and secondary outcomes, there were no significant differences between those who did and did not receive an attempted ECV. The full composite of the primary outcome included stillbirth, neonatal death within 72 hours, Apgar score less than five at five minutes, umbilical artery pH less than 7.0, base deficit 12 mmol/L or greater, or neonatal therapeutic hypothermia.

Analysis revealed that among women who underwent attempted ECV, more were non-Hispanic white, multiparous, and had a lower mean body mass index (BMI) at time of delivery compared with those who did not have an ECV attempt. Importantly, among the 40% of women who had successful ECV, as many as 79% delivered vaginally, whereas among those who did not undergo an ECV attempt and continued to have non-vertex fetal presentation at time of delivery, fewer than one percent ultimately delivered vaginally. The study was published in the August 2018 issue of Obstetrics & Gynecology.

“An ECV attempt at term is not associated with increased perinatal morbidity or mortality, compared with expectant management. Although success can be difficult to predict reliably, an ECV attempt does result in a significantly reduced chance of cesarean delivery,” concluded lead author Moeun Son, MD, and colleagues. “As such, these data support the existing recommendations that an ECV attempt should be encouraged when fetal malpresentation exists at term.”

ECV is a manual procedure by which an attempt is made to turn a breech baby from a buttocks- or foot-first position to a head-first position in order to enable vaginal delivery. It is usually performed after about 37 gestational weeks, as breech presentation greatly decreases after that. To perform ECV, both hands are placed on the mother's abdomen around the baby, who is then moved up and away from the pelvis and gently turned in several steps from breech, to a sideways position, and finally to a head first presentation.

Related Links:
Northwestern University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.